Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Jeena Sikho Lifecare LtdIndustry : Pharmaceuticals - Indian - Formulations
BSE Code:535446NSE Symbol: JSLLP/E(TTM):58.07
ISIN Demat:INE0J5801029Div & Yield %:0.23EPS(TTM):7.3
Book Value(Rs):21.9644845Market Cap ( Cr.):5269.11Face Value(Rs):2
    Change Company 
Date Headline
29-May-25 Jeena Sikho Lifecare Ltd - Updates
26-May-25 Jeena Sikho Lifecare Ltd - Analysts/Institutional Investor Meet/Con. Call Updates
22-May-25 Jeena Sikho Lifecare Ltd - Updates
21-May-25 Jeena Sikho Lifecare Ltd - Updates
20-May-25 Jeena Sikho Lifecare Ltd - General Updates
17-May-25 Jeena Sikho Lifecare Ltd - Updates
16-May-25 Board of Jeena Sikho Lifecare recommends final dividend
16-May-25 Jeena Sikho Lifecare Ltd - Outcome of Board Meeting-XBRL
16-May-25 Jeena Sikho Lifecare Ltd - Dividend
16-May-25 Jeena Sikho Lifecare Ltd - Outcome of Board Meeting
<< < 1 2 3 4   > >>